InsurTech Start-Ups: Friends or Foes?

The shift to collaborate, rather than compete, with technology start-ups is gathering pace throughout the financial services industry.

|
This is the second of two parts. The first was, "The InsurTech Boom Is Reshaping the Market." What is your strategy to respond to Insurtech? Yes, InsurTech start-ups may be rivals and disruptors….but savvy insurers are starting to recognize that InsurTech start-ups can also be partners. The benefits of InsurTech collaboration are substantial. While some carriers view the rise of insurance technology start-ups with trepidation, others have been quick to seize on the InsurTech trend as an opportunity. Major insurers are some of the biggest investors in fledgling InsurIech firms. Far from seeing these new companies as rivals, they’re embracing them as partners. The venture investment funds of prominent insurers such as AXA, Aviva, Allianz, American Family, MassMutual, TransAmerica and Ping An, have made significant investments in insurtech start-ups. Recipients include PolicyGenius, NextCapital, CoverHound and Limelight Health. Funding of emerging technology firms by big insurers looks set to climb this year. CB Insights reports that insurers completed 20 investment deals in the first quarter of this year. The same group of insurers concluded only eight deals in the first three months of 2015. See also: A Mental Framework for InsurTech The shift to collaborate, rather than compete, with technology start-ups is gathering pace throughout the financial services industry. Investment in start-ups aiming to collaborate with established financial services providers jumped 138% last year. It accounted for 44% of the total funding for financial services technology, FinTech, in 2015 – up from 29% in 2014. Start-ups looking to compete with financial services companies still attract the bulk of investment. However, there’s growing enthusiasm for cooperation among investors and start-ups. The extent of this support varies across geographic markets. In New York, investment in collaborative start-ups accounted for 83% of total FinTech funding, while in London and the rest of the U.K., where the regulatory environment is more conducive to new competitors, the proportion was only 10%. The illustration below shows the growing interest in cooperation across the financial services industry. Investors are increasingly supporting firms that can help established service providers reduce costs and risk and capitalize on new markets. Friend or foe. Big insurers shift stance on insurtech start-ups_Cusano (Figure 1) This trend is only beginning to affect the insurance industry. But as the InsurTech sector grows it will become much stronger. Increasing cooperation between insurers and new technology firms is a sure sign of the growing maturity of the InsurTech sector. Many major carriers no longer worry that InsurTech firms might erode their business. Instead, they’re eager to benefit from the new insights, attitudes and technology they bring to the industry. See also: Blockchain Technology and Insurance   The benefits of collaborating with InsurTech firms can be compelling and include:
  • Insurers can get early access, first mover advantage on disruptive technologies.
  • Big insurers' decisions to use new technologies often decide whether a new company will be successful….so combining use of a new InsurTech with an investment is a double win.
  • Insurers will get the ability to influence the strategy of the new start-up.
In my next blog post, I’ll discuss the shift in FinTech funding to developing economies and explain why this is good for insurers. This article originally appeared on Accenture.  

John Cusano

Profile picture for user JohnCusano

John Cusano

John Cusano is Accenture’s senior managing director of global insurance. He is responsible for setting the industry group's overall vision, strategy, investment priorities and client relationships. Cusano joined Accenture in 1988 and has held a number of leadership roles in Accenture’s insurance industry practice.

MORE FROM THIS AUTHOR

Read More